WADA 2026 Report: Testing Volume Growth Slows, 45% of Findings Sit in Sample Collection

In late 2026, with Saigon pools shut by the pandemic, I sat down with a GPS dataset covering 29 athletes and noticed something: most of the muscle-injury warning signals appeared weeks before the event itself. Since then, whenever a major report is published, I skip the headline and go straight to the slope of the curve.

The 2026 annual report from the World Anti-Doping Agency (WADA) is one such case. The headline speaks of rising sample testing. But once the data is separated out, growth is decelerating: 12.5% from 2026 to 2026, then just 3.2% from 2026 to 2026. Total samples still rose, from 288,865 to 297,965, roughly 9,100 additional tests in a single year. The momentum has clearly cooled, and that is a more notable starting point than the headline.

A document that sits one layer above the pool

This is a cross-sport governance report. It says nothing about stroke technique, nothing about underwater turns, nothing about any swimmer's qualification path. For someone who works with swimming data, this document sits one layer up: it shapes the environment every national swimming federation must operate inside. So I state the boundary up front: any swimming-related inference in this piece is extrapolation, not a technical conclusion.

One detail about the time label needs clearing before the numbers. A report titled 2026 draws most of its testing data from 2026 and 2026. That labelling convention is common in international governance bodies: published this year, figures from the previous year, a one-year lag. Anyone citing it without that caveat will misdate the cycle.

For Vietnamese swimming, the interesting part is the internal structure of the aggregate figure. Swimming is sample-intensive: a swimmer competing across multiple events can sit inside several testing programmes at once, in and out of competition. When system resources shift, swimming feels it before many other sports.

Three data layers to read together

The first layer is volume. The 2026–2026 series shows samples rising steadily, then flattening. Looking only at the two most recent markers, the picture sharpens: up 12.5%, then up 3.2%. A curve like that usually does not come from falling demand but from collection capacity hitting a ceiling.

The second layer is the Adverse Analytical Finding rate, meaning the share of samples returning a formal positive. The last three years: 0.77%, 0.80%, 0.78%. The swing is about 0.03 percentage points. This is the most stable figure in the entire report, stable enough to treat as a baseline signal rather than noise. Samples rose by 9,100 while the detection rate barely moved. Two explanations exist, and the data cannot separate them: either the underlying violation rate is flat, or sample selection improved to the point of reaching the right group with the same positivity probability.

The third layer is compliance. Across nine audits, average findings fell from 25.5 to 20. That sounds like progress. But when findings are broken down by type, the testing-related category rose 11%, making up 45% of all findings, with 23% rated critical. This is improvement with a hole in it: the total score looks better while the score at the most important point gets worse.

Then there is the money. WADA recorded a shortfall of 8.3 million USD against budget. The United States has not paid 3.8 million; Russia owes 3.9 million. At the same time, the organisation still reported a net surplus of 1.2 million USD. Large arrears on one side, a surplus on the other; those two facts only coexist if spending was cut or disbursement deferred somewhere.

On strategy, WADA records a shift away from the traditional testing model toward investigations and prevention: more than 250 operations, 88 laboratories dismantled, more than 90 tonnes seized. On the athlete side, more than 600 athletes and commissions from over 60 countries and more than 70 sports took part in consultation. And the system milestone: the 2027 edition of the World Anti-Doping Code was adopted in Busan, South Korea, effective from 1 January 2027.

Where it is easiest to go wrong

The counterintuitive point lies in assigning causation between two series that move at the same time. Slowing sample growth and a funding gap look very much like cause and effect. But to say money shortages reduce collection speed, I have to name a concrete mechanism: each additional sample requires more collection staff, more transport cost, more laboratory capacity. When any of those three hits a financial ceiling, growth slows in the very next cycle. The mechanism is plausible, but it remains a hypothesis. Better phrasing: the two series are related.

Every shock has its own probability. We call it a shock when we have not yet checked the table. There is no shock here, only a curve misread because of the headline.

One more point: there were only nine audits. The 20 versus 25.5 figure looks good on paper, but the sample base is far too small to call a trend. Anyone citing it as a settled achievement is reaching beyond the data.

And the part that cannot be quantified: two major nations stalling on contributions is a political event, not a technical one. It cannot be measured in percentage points. When a system depends on money it does not control, its shield is thinner than it appears. I keep a wide confidence interval around any judgement on this section.

The transition window

From now to 1 January 2027 lies a regulatory gap. Inside it, conduct under the old rules continues in many places, while obligations under the new rules are already visible on paper. A tactical era dies when nobody reads its data table anymore.

For swimming federations, four indicators are worth tracking in the next report: whether sample growth has bottomed out; whether the AAF rate breaks above 0.85%; whether the share of collection-stage findings passes 45%; and the contribution status of major nations.

One swim happens on one morning. Its trajectory lasts for years. A governance report works the same way: it decides no one's result, but it decides who gets tested, where, and when. Over time, that touches every lane.